Health Care " BriaCell (TSX:BCT) signs research agreement to identify novel targets for cancer treatment BriaCell Therapeutics (BCT) has announced a research collaboration with Harvard Medical School, supporting a project led by Joan S. Brugge, Ph.D. Azuka Onwuka2 mins29 June 2022 10:45 (EDT)
Health Care " BriaCell (TSX:BCT) advances towards new breast cancer treatment clinical trial BriaCell Therapeutics Corp. (BCT) is manufacturing its novel off-the-shelf (OTS) personalized immunotherapy, Bria-OTS™, a treatment against advanced breast cancer. Caroline Egan2 mins07 April 2022 12:15 (EDT)
Health Care " Marc Lustig joins BriaCell Therapeutics’ (TSXV:BCT) Board of Directors BriaCell Therapeutics (BCT) welcomes Mr. Marc Lustig to the company’s Board of Directors, effective September 1, 2021. John Ballem2 mins01 September 2021 10:45 (EDT)
Health Care " BriaCell (TSXV:BCT) expands breast cancer technology BriaCell Therapeutics (BCT) has expanded its breast cancer platform technology into prostate, melanoma and lung cancers. Trevor Abes2 mins16 June 2021 13:45 (EDT)
